Acumen Pharmaceuticals Inc
Acumen Pharmaceuticals Inc (ABOS) Option Chain
Read more
Tracking the ABOS option chain helps you see every strike and expiry on Acumen Pharmaceuticals Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ABOS options activity at a glance. Use our scanner to monitor the ABOS option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ABOS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ABOS options are being actively traded, and where they are not.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 90.73 | 0 | 40 | 0.05 | 0.00 | — | 0.05 | 0.50 | +138.10 | — | 0.65 | 0.29 | 0.36 | 25 | 10 | 9.27 |
| 97.20 | 0 | 0 | 1.00 | 0.00 | — | 1.00 | 1.00 | +376.19 | 0.75 | 1.45 | 0.79 | 0.31 | 7 | 13 | 2.80 |
| 98.79 | 0 | 0 | 1.00 | 0.00 | — | 1.00 | 1.50 | +614.29 | 1.20 | 2.20 | 1.29 | 0.41 | 25 | 8 | 1.21 |
| 99.38 | 0 | 0 | 1.00 | 0.00 | — | 1.00 | 2.00 | +852.38 | 1.75 | 2.05 | 1.79 | 0.11 | 35 | 15 | 0.62 |
| 99.64 | 738 | 0 | 0.05 | 0.00 | — | 0.05 | 2.50 | +1090.48 | 1.80 | 2.50 | 2.29 | -0.14 | 25 | 48 | 0.36 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank96.43% High
- Market cap (M$)15
- 52 weeks high-94.17%
- 52 weeks low10.53%
- Analyst recommendationHold
3.20 - Target price$1.00
376.19% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-10-26
- P/E—
- Future P/E—
- EPS (ttm)-1.55
- EPS growth next 5 years50.45%
As of Nov 13, 2026